IBL International Overview

  • Founded
  • 1983
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 82
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $35.8M
Latest Deal Amount

IBL International General Information

Description

Producer of immunoassays and antibodies. The company focuses on assays for rare indications, including immunoassays for the measurement of neurodegenerative diseases, neonatal screening and the diagnosis of stress parameters and steroid hormones in saliva.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Distributors/Wholesale
Other Industries
Other Pharmaceuticals and Biotechnology
Other Devices and Supplies
Other Healthcare
Acquirer
Primary Office
  • Flughafenstraße 52a
  • 22335 Hamburg
  • Germany
+49 040 0000000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IBL International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 30-Aug-2014 $35.8M 000.00 Completed Generating Revenue
4. Grant 16-Aug-2012 Completed Product Development
3. Grant 01-Jan-2009 Completed Product Development
2. Later Stage VC Completed
1. Later Stage VC 30-Sep-2008 Completed Product Development
To view IBL International’s complete valuation and funding history, request access »

IBL International Executive Team (6)

Name Title Board Seat Contact Info
Mana Shafaei Director of Sales
Dirk Bottcher Head, Finance
Gerd Neubert Head, Sales
You’re viewing 3 of 6 executive team members. Get the full list »

IBL International Board Members (3)

Name Representing Role Since
Jan Groen Ph.D Self Board Member 000 0000
Willem van Hulsenbeek Self Chairman 000 0000
To view IBL International’s complete board members history, request access »

IBL International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IBL International Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Oost NL Venture Capital Minority 000 0000 000000 0
Wadinko Venture Capital Majority 000 0000 000000 0
To view IBL International’s complete investors history, request access »